A STUDY OF BUYING BEHAVIOURAL PATTERN OF GENERIC DRUGS AND BRANDED DRUGS

Authors

  • Mariam Department of Pharmaceutical Analysis, Chaitanya (Deemed to be University), Hanumakonda, Telangana, India
  • N. Dora Babu Department of Pharmacy, University College of Technology, Osmania University Main Rd, Amberpet, Hyderabad, Telangana-500007

Keywords:

Generic drugs, Branded drugs, Behavioural pattern, Promotion

Abstract

The pharmaceutical industry in India is dominated by physicians and patients. They have a lot of options for treatments and surgeries. This calls for a higher dependence on scenario-based planning, a more intense focus on obtaining productivity benefits from sales and marketing expenditures, and demonstrating the worth of medications. Consumers are increasingly being marketed to and sold prescription medications using conventional marketing strategies like advertising and promotion. As a result, branding will have more of an impact on how patients and doctors behave and think. The pharmaceutical industry in India is dominated by physicians and patients. They have a lot of options for treatments and surgeries. In order to achieve this, scenario-based planning must be used more frequently, productivity gains from sales and marketing expenditures must be prioritised more intensely.

References

Aaker, D. and Joachimstaler, E., Brand Leadership, New York: Free Press, 2000.

Aaker, David A., Managing brand equity - Capitalising on the value of a brand name, 1991, The Free Press, New York.

Adarkar, Ashwin, Krishnan, Sankar, and Viswanathan, Sanoke, India’s pharma challenge, The Mckinsey Quarterly, No. 1, 2001, pg. 126-127.

Audit Commission, A prescription for movement towards more rational prescribing in general practice, London: Audit Commission, 1996, pg. 9-12.

Avery, A. J., Wetzels, R. V., and Rodgers, S., Do GPs working in practice with high or low prescribing costs have different views on prescribing cost issues? Br J Gen Pract, 2000; 50:100 4.

AyurvednoItihas, 1st edition, (1968) by Pdt. Hemraj Sharma, Translated by Shri. G. M. Shastri, pg. 11-19, 37, 48-51,462-467.

Baker, D., and Klein, R., Explaining outputs of primary health care: population and practice factors, BMJ, 1991; 303:225-9.

Becker, M. H., Stolley, P., and Lasagna, L., Correlates of physicians’ prescribing behaviour, Inquiry, 1972; 9:30-42.

Bemdt, Ernst R., Linda T., Bui, Reiley, David H., and Urban, Glen L., The roles of marketing, product quality, and price competition in the growth and composition of the U.S. Anti-Ulcer drug industry, Working paper No. 19-94,

Bhardwaj, Preshth, Indian Pharmaceutical Market: An outsourcing destination, GITAM Journal of Management, Vol. 3, No. 1,2005, pg. 114-127.

Blackett, T., Brand medicine: Use and future potential of branding in pharmaceutical markets, International Journal of Medical Marketing, 2001.

Blackett, T., Brands and Branding, Interbrand, New York, 2004.

Bradley, C., Factors which influence the decision whether or not to prescribe: the dilemma facing general practitioners, Br J Gen Pract, 1992; 42:454-8.

Britten, N., Patient demand for prescriptions: a view from the other side, Family Practice, 2000; 11: 62-66.

Buchholz, A. and Wordemann, W., What makes winning brands different? The hidden method behind the world’s most successful brands. John Wiley & Sons ltd, England, 2000.

Calfee, John E., The role of marketing in pharmaceutical research and development, Pharmacoeconomics 2002; 20 Suppl., 3: 77-85.

Carrin, G., Drug prescribing: a discussion of its variability and (irrationality, Health Policy, 1987; 73-94.

Published

02-12-2023

How to Cite

Mariam, & Babu, N. D. (2023). A STUDY OF BUYING BEHAVIOURAL PATTERN OF GENERIC DRUGS AND BRANDED DRUGS. Well Testing Journal, 32, 46–57. Retrieved from https://welltestingjournal.com/index.php/WT/article/view/64

Issue

Section

Research Articles